Medical Developments International Limited (ASX:MVP)
0.4600
+0.0200 (4.55%)
Jul 31, 2026, 4:10 PM AEST
ASX:MVP Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 52 | 62 | 35 | 67 | 104 | 321 | |
Market Cap Growth | -32.85% | 77.27% | -47.74% | -35.75% | -67.54% | -29.99% |
Enterprise Value | 37 | 46 | 22 | 32 | 79 | 290 |
Last Close Price | 0.46 | 0.55 | 0.39 | 0.75 | 1.40 | 4.31 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | - | 659.17 | - | - | - | - |
Forward PE | 54.12 | 22.54 | 208.39 | 208.39 | 208.39 | 208.39 |
PS Ratio | 1.28 | 1.59 | 1.05 | 2.07 | 4.74 | 12.69 |
PB Ratio | 0.95 | 1.12 | 0.76 | 0.82 | 1.82 | 4.70 |
P/TBV Ratio | 1.56 | 1.26 | 0.88 | 0.88 | 2.01 | 5.15 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 0.90 | 1.19 | 0.65 | 1.00 | 3.59 | 11.49 |
EV/EBITDA Ratio | 17.80 | 27.77 | - | - | - | - |
EV/EBIT Ratio | 74.60 | 329.69 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.03 | 0.04 | 0.05 | 0.03 | 0.05 | 0.05 |
Debt / EBITDA Ratio | 0.89 | 1.02 | - | - | - | - |
Net Debt / Equity Ratio | -0.28 | -0.29 | -0.16 | -0.27 | -0.31 | -0.49 |
Net Debt / EBITDA Ratio | -8.38 | -9.47 | 0.60 | 1.39 | 1.55 | 17.08 |
Net Debt / FCF Ratio | -30.95 | 32.61 | 0.64 | 1.21 | 1.47 | 3.28 |
Asset Turnover | 0.63 | 0.62 | 0.41 | 0.33 | 0.23 | 0.27 |
Inventory Turnover | 1.31 | 1.06 | 1.02 | 1.31 | 1.05 | 0.82 |
Quick Ratio | 4.38 | 3.26 | 1.76 | 2.16 | 2.54 | 5.93 |
Current Ratio | 6.07 | 4.54 | 2.74 | 2.75 | 3.28 | 6.81 |
Return on Equity (ROE) | -0.79% | 0.19% | -64.53% | -8.09% | -19.76% | -22.51% |
Return on Assets (ROA) | 0.48% | 0.14% | -11.00% | -11.18% | -8.15% | -2.35% |
Return on Invested Capital (ROIC) | 1.24% | 0.20% | -28.96% | -34.98% | -33.55% | -10.49% |
Return on Capital Employed (ROCE) | 0.80% | 0.20% | -28.50% | -20.20% | -15.30% | -3.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | -0.84% | 0.15% | -117.27% | -8.39% | -11.92% | -3.92% |
FCF Yield | 0.94% | -0.78% | -33.11% | -27.33% | -11.50% | -3.16% |
Buyback Yield / Dilution | -16.32% | -29.95% | -2.41% | -18.23% | -4.11% | -3.88% |
Total Shareholder Return | -16.32% | -29.95% | -2.41% | -18.23% | -4.11% | -3.88% |